We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $764M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$453M
AUM Growth
-$25.1M
Cap. Flow
-$4.08M
Cap. Flow %
-0.9%
Top 10 Hldgs %
86.52%
Holding
85
New
10
Increased
5
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$1.3M
2
NVDA icon
NVIDIA
NVDA
+$1.3M
3
SNOW icon
Snowflake
SNOW
+$1.27M
4
META icon
Meta Platforms (Facebook)
META
+$1.24M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.2M

Top Sells

Rank Stock Value
1
JBGS
JBG SMITH
JBGS
+$9.46M
2
SPB icon
Spectrum Brands
SPB
+$781K
3
CHRA
Charah Solutions, Inc Common Stock
CHRA
+$550K
4
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$442K
5
ELVN icon
Enliven Therapeutics
ELVN
+$388K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.24%
2 Technology 14.93%
3 Energy 13.16%
4 Financials 3.61%
5 Communication Services 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
76
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-3,000
Closed -$473K
SWKH
77
DELISTED
SWK Holdings
SWKH
– –
-10,544
Closed -$140K
TECK icon
78
Teck Resources
TECK
$31.3B
– –
-3,616
Closed -$152K
PRDS
79
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-43,998
Closed -$79.6K
APGN
80
DELISTED
Apexigen, Inc. Common Stock
APGN
– –
-9,130
Closed -$3.92K
KDNY
81
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-11,500
Closed -$442K
GRNA
82
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
– –
-50,000
Closed -$14.9K
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-5,000
Closed -$197K
STCN
84
DELISTED
Steel Connect, Inc. Common Stock
STCN
– –
-7,026
Closed -$58.9K
CHRA
85
DELISTED
Charah Solutions, Inc Common Stock
CHRA
– –
-94,000
Closed -$550K
1 2 3
4

Similar funds

CCIP
Camrose Capital Investment Partners London, United Kingdom $764M AUM 0.9% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
PGA
Pilgrim Global Advisors Reno, Nevada $772M AUM 51.79% 1-Year Est. Return

JBF Capital's Q3 2023 Portfolio in Review

As of Q3 2023, JBF Capital held 85 positions worth $453M, down 5.3% from $478M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

JBF Capital's Q3 2023 filing shows 10 new, 5 increased, 5 reduced and 20 closed positions. Its largest new stake was Broadcom: 15,000 shares worth $1.25M. The largest sale was JBG SMITH, an estimated $9.46M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 24% a quarter earlier, followed by Technology and Energy.

  • JBF Capital's largest Q3 2023 buy was Broadcom: 15,000 shares worth $1.25M.
  • JBF Capital added most to Apple in Q3 2023, an estimated $734K increase.
  • JBF Capital's biggest Q3 2023 reduction was Enliven Therapeutics, cutting an estimated $388K.
  • JBF Capital fully exited JBG SMITH in Q3 2023, selling an estimated $9.46M.
  • JBF Capital's ten largest holdings make up 87% of its $453M portfolio in Q3 2023.
  • JBF Capital opened 10 new positions and closed 20 in Q3 2023.
  • JBF Capital's portfolio value fell 5.3% quarter-over-quarter to $453M.

Based on JBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.